BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 17804776)

  • 21. Intraprocedural Versus Initial Follow-up Minimal Ablative Margin Assessment After Colorectal Liver Metastasis Thermal Ablation: Which One Better Predicts Local Outcomes?
    Lin YM; Paolucci I; Albuquerque Marques Silva J; O'Connor CS; Fellman BM; Jones AK; Kuban JD; Huang SY; Metwalli ZA; Brock KK; Odisio BC
    Invest Radiol; 2024 Apr; 59(4):314-319. PubMed ID: 37812469
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Liver metastases: 3D shape-based analysis of CT scans for detection of local recurrence after radiofrequency ablation.
    Bricault I; Kikinis R; Morrison PR; Vansonnenberg E; Tuncali K; Silverman SG
    Radiology; 2006 Oct; 241(1):243-50. PubMed ID: 16928977
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Multipolar hepatic radiofrequency ablation using up to six applicators: preliminary results.
    Bruners P; Schmitz-Rode T; Günther RW; Mahnken A
    Rofo; 2008 Mar; 180(3):216-22. PubMed ID: 18278730
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Central lower attenuating lesion in the ablation zone on immediate follow-up CT after percutaneous radiofrequency ablation for hepatocellular carcinoma: incidence and clinical significance.
    Park Y; Choi D; Rhim H; Kim YS; Lee JY; Chang I; Lim HK; Park CK
    Eur J Radiol; 2010 Sep; 75(3):391-6. PubMed ID: 19467813
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Increase in volume of ablation zones during follow-up is highly suggestive of ablation site recurrence in colorectal liver metastases treated with radiofrequency ablation.
    Kele PG; de Jong KP; van der Jagt EJ
    J Vasc Interv Radiol; 2012 Apr; 23(4):537-44. PubMed ID: 22341635
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Radiofrequency ablation for liver metastasis from gastrointestinal stromal tumor.
    Yamanaka T; Takaki H; Nakatsuka A; Uraki J; Fujimori M; Hasegawa T; Sakuma H; Yamakado K
    J Vasc Interv Radiol; 2013 Mar; 24(3):341-6. PubMed ID: 23352855
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Local Tumor Progression Predictive Model Based on MRI for Colorectal Cancer Liver Metastases after Radiofrequency Ablation.
    Zhang G; Liu P; Wang G; He X; Xu L; Wang Y; Li W; Peng W
    Discov Med; 2024 Apr; 36(183):765-777. PubMed ID: 38665025
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Predictive value of pattern classification 24 hours after radiofrequency ablation of liver metastases on CT and positron emission tomography/CT.
    Vandenbroucke F; Vandemeulebroucke J; Ilsen B; Verdries D; Belsack D; Everaert H; Buls N; Ros PR; de Mey J
    J Vasc Interv Radiol; 2014 Aug; 25(8):1240-9. PubMed ID: 24954606
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact of the Ablative Margin on Local Tumor Progression after Radiofrequency Ablation for Lung Metastases from Colorectal Carcinoma: Supplementary Analysis of a Phase II Trial (MLCSG-0802).
    Hasegawa T; Takaki H; Kodama H; Matsuo K; Yamanaka T; Nakatsuka A; Takao M; Gobara H; Hayashi S; Inaba Y; Yamakado K
    J Vasc Interv Radiol; 2023 Jan; 34(1):31-37.e1. PubMed ID: 36209996
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mid-term outcome of positron emission tomography/computed tomography-assisted radiofrequency ablation in primary and secondary liver tumours--a single-centre experience.
    Kuehl H; Stattaus J; Hertel S; Hunold P; Kaiser G; Bockisch A; Forsting M
    Clin Oncol (R Coll Radiol); 2008 Apr; 20(3):234-40. PubMed ID: 18155453
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Unresectable colorectal liver metastases: percutaneous ablation using CT-guided high-dose-rate brachytherapy (CT-HDBRT).
    Collettini F; Lutter A; Schnapauff D; Hildebrandt B; Puhl G; Denecke T; Wust P; Gebauer B
    Rofo; 2014 Jun; 186(6):606-12. PubMed ID: 24407711
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ablative safety margin depicted by fusion imaging with post-treatment contrast-enhanced ultrasound and pre-treatment CECT/CEMRI after radiofrequency ablation for liver cancers.
    Bo XW; Xu HX; Guo LH; Sun LP; Li XL; Zhao CK; He YP; Liu BJ; Li DD; Zhang K; Wang D
    Br J Radiol; 2017 Oct; 90(1078):20170063. PubMed ID: 28749166
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ablative Margins of Colorectal Liver Metastases Using Deformable CT Image Registration and Autosegmentation.
    Lin YM; Paolucci I; O'Connor CS; Anderson BM; Rigaud B; Fellman BM; Jones KA; Brock KK; Odisio BC
    Radiology; 2023 Apr; 307(2):e221373. PubMed ID: 36719291
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Histopathologic and immunohistochemical features of tissue adherent to multitined electrodes after RF ablation of liver malignancies can help predict local tumor progression: initial results.
    Sofocleous CT; Nascimento RG; Petrovic LM; Klimstra DS; Gonen M; Brown KT; Brody LA; Covey AM; Thornton RH; Fong Y; Solomon SB; Schwartz LH; DeMatteo RP; Getrajdman GI
    Radiology; 2008 Oct; 249(1):364-74. PubMed ID: 18796687
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Growth rate of new hepatocellular carcinoma after percutaneous radiofrequency ablation: evaluation with multiphase CT.
    Park Y; Choi D; Lim HK; Rhim H; Kim YS; Kim SH; Lee WJ
    AJR Am J Roentgenol; 2008 Jul; 191(1):215-20. PubMed ID: 18562748
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of FDG-PET, PET/CT and MRI for follow-up of colorectal liver metastases treated with radiofrequency ablation: initial results.
    Kuehl H; Antoch G; Stergar H; Veit-Haibach P; Rosenbaum-Krumme S; Vogt F; Frilling A; Barkhausen J; Bockisch A
    Eur J Radiol; 2008 Aug; 67(2):362-371. PubMed ID: 18155866
    [TBL] [Abstract][Full Text] [Related]  

  • 37. CT-guided radiofrequency ablation in patients with hepatic metastases from breast cancer.
    Jakobs TF; Hoffmann RT; Schrader A; Stemmler HJ; Trumm C; Lubienski A; Murthy R; Helmberger TK; Reiser MF
    Cardiovasc Intervent Radiol; 2009 Jan; 32(1):38-46. PubMed ID: 18575933
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Percutaneous radiofrequency ablation of liver tumors using the LeVeen 4 cm array probe].
    Pitton MB; Herber S; Raab P; Mönch C; Wunsch M; Schneider J; Schweden F; Otto G; Thelen M
    Rofo; 2003 Nov; 175(11):1525-31. PubMed ID: 14610704
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Percutaneous radiofrequency thermoablation as an alternative to surgery for treatment of liver tumour recurrence after hepatectomy.
    Elias D; De Baere T; Smayra T; Ouellet JF; Roche A; Lasser P
    Br J Surg; 2002 Jun; 89(6):752-6. PubMed ID: 12027986
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Three-dimensional registration of images obtained before and after radiofrequency ablation of hepatocellular carcinoma to assess treatment adequacy.
    Sakakibara M; Ohkawa K; Katayama K; Imanaka K; Ishihara A; Hasegawa N; Kimura H
    AJR Am J Roentgenol; 2014 May; 202(5):W487-95. PubMed ID: 24758684
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.